(function(){var loadHandler=window['sl_{95E1BEEB-F09F-45AD-952C-441D2D154419}'];loadHandler&&loadHandler(23, '<div id="spr0_128e697"><div id="spr1_128e697" class="kern"><img id="img3_128e697" src="data/img2.png" width="960px" height="540px" alt="" style="left:0px;top:0px;"/><div id="spr3_128e697"><img id="img0_128e697" src="data/img0.png" width="960" height="540" alt=""/></div></div><div id="spr2_128e697" class="kern"><div id="spr4_128e697" style="left:179.494px;top:88.818px;"><img id="img1_128e697" src="data/img68.png" width="464" height="121" alt="" style="left:0.041px;top:0.106px;"/></div><div id="spr5_128e697" style="left:788.602px;top:60.213px;"><img id="img2_128e697" src="data/img69.png" width="113" height="130" alt="" style="left:0.092px;top:0.204px;"/></div><div id="spr6_128e697" style="left:6.742px;top:254.621px;"><div style="width:0px;"><span id="txt0_128e697" class="relpos" style="left:7.2px;top:2.734px;">RCT:EUS-BD or ERCP</span></div><div style="width:0px;"><span id="txt1_128e697" class="relpos" style="left:7.2px;top:29.056px;">Unresectable MBO, N=125</span></div><div style="width:0px;"><span id="txt2_128e697" class="relpos" style="left:203.7px;top:55.456px;">EUS-BD </span><span id="txt3_128e697" class="relpos" style="left:226.685px;top:55.456px;">ERCP</span></div><div style="width:0px;"><span id="txt4_128e697" class="relpos" style="left:7.2px;top:81.856px;">Technical success </span><span id="txt5_128e697" class="relpos" style="left:60.53px;top:81.856px;">93.8% </span><span id="txt6_128e697" class="relpos" style="left:92.025px;top:81.856px;">90.2% </span><span id="txt7_128e697" class="relpos" style="left:94.77px;top:81.856px;">P = 0.003</span></div><div style="width:0px;"><span id="txt8_128e697" class="relpos" style="left:7.2px;top:103.534px;">(Noninferiority)</span></div><div style="width:0px;"><span id="txt9_128e697" class="relpos" style="left:7.2px;top:129.856px;">Clinical success </span><span id="txt10_128e697" class="relpos" style="left:75.445px;top:129.856px;">90.0% </span><span id="txt11_128e697" class="relpos" style="left:106.94px;top:129.856px;">94.5% </span><span id="txt12_128e697" class="relpos" style="left:109.685px;top:129.856px;">P = 0.49</span></div><div style="width:0px;"><span id="txt13_128e697" class="relpos" style="left:7.2px;top:156.256px;">Stent patency at 6M</span><span id="txt14_128e697" class="relpos" style="left:41.445px;top:156.256px;">85.1% </span><span id="txt15_128e697" class="relpos" style="left:72.94px;top:156.256px;">48.9% </span><span id="txt16_128e697" class="relpos" style="left:75.685px;top:156.256px;">P = 0.0001</span></div><div style="width:0px;"><span id="txt17_128e697" class="relpos" style="left:7.2px;top:182.656px;">Adverse events </span><span id="txt18_128e697" class="relpos" style="left:84.695px;top:182.656px;">6.3% </span><span id="txt19_128e697" class="relpos" style="left:121.19px;top:182.656px;">19.7%</span><span id="txt20_128e697" class="relpos" style="left:128.935px;top:182.656px;">P = 0.03</span></div><div style="width:0px;"><span id="txt21_128e697" class="relpos" style="left:49.45px;top:209.056px;">Pancreatitis</span><span id="txt22_128e697" class="relpos" style="left:133.805px;top:209.056px;">0 </span><span id="txt23_128e697" class="relpos" style="left:187.8px;top:209.056px;">14.8%</span><span id="txt24_128e697" class="relpos" style="left:195.545px;top:209.056px;">P = 0.0001</span></div></div><div id="spr7_128e697" style="left:489.177px;top:281.34px;"><div style="width:0px;"><span id="txt25_128e697" class="relpos" style="left:7.2px;top:4.665px;">Technical feasibility: </span><span id="txt26_128e697" class="relpos" style="left:17.155px;top:4.665px;">EUS-BD = ERCP</span></div><div style="width:0px;"><span id="txt27_128e697" class="relpos" style="left:7.2px;top:28.665px;">Stent patency: </span><span id="txt28_128e697" class="relpos" style="left:70.57px;top:28.665px;">EUS-BD &gt; ERCP</span></div><div style="width:0px;"><span id="txt29_128e697" class="relpos" style="left:7.2px;top:52.665px;">Patients’ QOL:</span><span id="txt30_128e697" class="relpos" style="left:68.305px;top:52.665px;">EUS-BD &gt; ERCP</span></div><div style="width:0px;"><span id="txt31_128e697" class="relpos" style="left:7.2px;top:76.665px;">Adverse event:  </span><span id="txt32_128e697" class="relpos" style="left:61.07px;top:76.665px;">EUS-BD &gt; ERCP</span></div></div></div></div>');})();